A novel lncRNA BF368575 promotes cell proliferation in hepatocellular carcinoma via PI3K/AKT/mTOR signaling pathway

Author:

zeng xiaohui1,Liu Chang1,He Qingjun2,Zou Zhaowei3,Liao Quanxing4,Wu Cheng3,Li Guanger1,Zhang Zezhong1,Tian Yun5,Zhu Siyu1,Yang Xianzi1,Cui Shuzhong1,Zeng Lisi1

Affiliation:

1. Affiliated Cancer Hospital & Institute of Guangzhou Medical University

2. Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University

3. Zhujiang Hospital, Southern Medical University

4. The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital

5. Zhaoqing Medical College

Abstract

Abstract Purpose LncRNA-BF368575 is a novel long non-coding RNA, its biological function in hepatocellular carcinoma (HCC) remains unknown. Methods The expression levels of lncRNA-BF368575 in HCC tissues and cell lines were evaluated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). In situ hybridization (ISH) was performed to determine the expression of lncRNA-BF368575 in a tissue chip containing 89 paired HCC and para-cancerous tissues. Fractionation of nuclear and cytoplasmic RNA was performed to determine the subcellular localization of lncRNA-BF368575. Cell viability and colony-forming ability were determined by cell counting kit-8 (CCK-8) assay and colony formation assay. Tumor growth in vivo was detected using the xenograft model. The molecular mechanisms of lncRNA-BF368575 were investigated using Western blotting and RNA-Binding Protein Immunoprecipitation (RIP). Results The results showed that lncRNA-BF368575 was increased in most HCC tissues and cell lines. Moreover, the lower lncRNA-BF368575 expression level is a favorable prognostic factor in disease-free survival (DFS). LncRNA-BF368575 is mostly localized in the cytoplasm. In vitro and in vivo experiments showed that downregulation of lncRNA-BF368575 suppressed cell proliferation and colony-forming activity, yet overexpression of lncRNA-BF368575 leads to an opposite result. Furthermore, lncRNA-BF368575 activates the PI3K/AKT/mTOR signaling pathway by increasing the expression of p-PI3K(Tyr607), p-AKT(Thr308), p-mTOR(Ser2448), p-4E-BP1(Thr37/46), p-S6(Ser235/236). LY294002 could reverse the biological functions of lncRNA-BF368575. RIP shows that LncRNA-BF368575 could bind to p-mTOR(Ser2448), p-AKT(Thr308), and p-4E-BP1(Thr37/46). Conclusion Our study demonstrates that lncRNA-BF368575 enhances HCC proliferation and growth both in vitro and vivo via activating the PI3K/AKT/mTOR signaling pathway, which implicates that our findings may provide a potential target for HCC treatments.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3